# Study of Major Cardiovascular Events in Patients With Nonvalvular Atrial Fibrillation Treated With Rivaroxaban

> **NCT02975453** · — · COMPLETED · sponsor: **Bayer** · enrollment: 1481 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Rivaroxaban (Xarelto, BAY59-7939)

## Key facts

- **NCT ID:** NCT02975453
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-05
- **Primary completion:** 2020-03-18
- **Final completion:** 2020-08-26
- **Target enrollment:** 1481 (ACTUAL)
- **Last updated:** 2023-11-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02975453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02975453, "Study of Major Cardiovascular Events in Patients With Nonvalvular Atrial Fibrillation Treated With Rivaroxaban". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02975453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*